HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $669,246 | -20.2% | 7,413 | -24.7% | 0.00% | – |
| Q2 2023 | $838,656 | -29.3% | 9,848 | -33.5% | 0.00% | -100.0% |
| Q4 2022 | $1,186,357 | +8.1% | 14,820 | +5.1% | 0.00% | – |
| Q3 2022 | $1,097,000 | -64.1% | 14,100 | -69.8% | 0.00% | -100.0% |
| Q2 2022 | $3,057,000 | +50.4% | 46,712 | +41.4% | 0.00% | 0.0% |
| Q1 2022 | $2,033,000 | +355.8% | 33,039 | +300.3% | 0.00% | – |
| Q4 2021 | $446,000 | -79.5% | 8,254 | -73.1% | 0.00% | -100.0% |
| Q3 2021 | $2,177,000 | -70.9% | 30,741 | -72.2% | 0.00% | -75.0% |
| Q2 2021 | $7,486,000 | -31.4% | 110,776 | +15.4% | 0.00% | -42.9% |
| Q1 2021 | $10,919,000 | -25.9% | 95,968 | -18.0% | 0.01% | -30.0% |
| Q4 2020 | $14,744,000 | +17.6% | 117,088 | -12.1% | 0.01% | 0.0% |
| Q3 2020 | $12,534,000 | +239.2% | 133,205 | +213.9% | 0.01% | +233.3% |
| Q2 2020 | $3,695,000 | +218.3% | 42,432 | +264.6% | 0.00% | +200.0% |
| Q1 2020 | $1,161,000 | -17.7% | 11,638 | -5.2% | 0.00% | 0.0% |
| Q4 2019 | $1,410,000 | +54.1% | 12,277 | +69.2% | 0.00% | 0.0% |
| Q3 2019 | $915,000 | +39.1% | 7,254 | +32.7% | 0.00% | 0.0% |
| Q2 2019 | $658,000 | +467.2% | 5,466 | +313.2% | 0.00% | – |
| Q1 2019 | $116,000 | -43.4% | 1,323 | -35.5% | 0.00% | – |
| Q4 2018 | $205,000 | +2.5% | 2,052 | +17.8% | 0.00% | – |
| Q3 2018 | $200,000 | -46.7% | 1,742 | -58.2% | 0.00% | – |
| Q2 2018 | $375,000 | +264.1% | 4,172 | +195.7% | 0.00% | – |
| Q1 2018 | $103,000 | +39.2% | 1,411 | +9.8% | 0.00% | – |
| Q4 2017 | $74,000 | +42.3% | 1,285 | +10.4% | 0.00% | – |
| Q3 2017 | $52,000 | +13.0% | 1,164 | 0.0% | 0.00% | – |
| Q2 2017 | $46,000 | +2.2% | 1,164 | +4.9% | 0.00% | – |
| Q1 2017 | $45,000 | +45.2% | 1,110 | +42.9% | 0.00% | – |
| Q4 2016 | $31,000 | -3.1% | 777 | -12.1% | 0.00% | – |
| Q3 2016 | $32,000 | +28.0% | 884 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | -58.3% | 884 | -48.7% | 0.00% | – |
| Q1 2016 | $60,000 | -75.8% | 1,722 | -77.6% | 0.00% | – |
| Q4 2015 | $248,000 | +18.7% | 7,693 | +19.2% | 0.00% | – |
| Q3 2015 | $209,000 | -48.3% | 6,456 | -33.9% | 0.00% | – |
| Q2 2015 | $404,000 | -9.4% | 9,766 | -1.7% | 0.00% | -100.0% |
| Q1 2015 | $446,000 | +14.1% | 9,930 | -5.1% | 0.00% | – |
| Q4 2014 | $391,000 | +541.0% | 10,461 | +497.1% | 0.00% | – |
| Q3 2014 | $61,000 | -18.7% | 1,752 | -17.4% | 0.00% | – |
| Q2 2014 | $75,000 | +167.9% | 2,121 | +147.5% | 0.00% | – |
| Q1 2014 | $28,000 | -51.7% | 857 | -38.2% | 0.00% | – |
| Q4 2013 | $58,000 | -47.7% | 1,387 | -50.2% | 0.00% | – |
| Q3 2013 | $111,000 | +94.7% | 2,787 | +100.9% | 0.00% | – |
| Q2 2013 | $57,000 | – | 1,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |